Green S, Buchbinder R, Glazier R, Forbes A
Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia.
BMJ. 1998 Jan 31;316(7128):354-60. doi: 10.1136/bmj.316.7128.354.
To review the efficacy of common interventions for shoulder pain.
All randomised controlled trials of non-steroidal anti-inflammatory drugs, intra-articular and subacromial glucocorticosteroid injection, oral glucocorticosteroid treatment, physiotherapy, manipulation under anaesthesia, hydrodilatation, and surgery for shoulder pain that were identified by computerised and hand searches of the literature and had a blinded assessment of outcome were included.
Methodological quality (score out of 40), selection criteria, and outcome measures. Effect sizes were calculated and combined in a pooled analysis if study population, end point, and intervention were comparable.
Thirty one trials met inclusion criteria. Mean methodological quality score was 16.8 (9.5-22). Selection criteria varied widely, even for the same diagnostic label. There was no uniformity in the outcome measures used, and their measurement properties were rarely reported. Effect sizes for individual trials were small (range -1.4 to 3.0). The results of only three studies investigating "rotator cuff tendinitis" could be pooled. The only positive finding was that subacromial steroid injection is better than placebo in improving the range of abduction (weighted difference between means 35 degrees (95% confidence interval 14 to 55)).
There is little evidence to support or refute the efficacy of common interventions for shoulder pain. As well as the need for further well designed clinical trials, more research is needed to establish a uniform method of defining shoulder disorders and developing outcome measures which are valid, reliable, and responsive in affected people.
回顾常见肩部疼痛干预措施的疗效。
纳入所有通过计算机检索和手工检索文献确定的、对结果进行盲法评估的关于非甾体抗炎药、关节内和肩峰下糖皮质激素注射、口服糖皮质激素治疗、物理治疗、麻醉下手法治疗、液压扩张及肩部疼痛手术的随机对照试验。
方法学质量(满分40分)、纳入标准和结局指标。若研究人群、终点和干预措施具有可比性,则计算效应量并进行汇总分析。
31项试验符合纳入标准。方法学质量平均得分为16.8(9.5 - 22)。纳入标准差异很大,即使是针对相同的诊断标签。所使用的结局指标缺乏一致性,且很少报告其测量特性。各试验的效应量较小(范围为 - 1.4至3.0)。仅能汇总三项针对“肩袖肌腱炎”的研究结果。唯一的阳性发现是肩峰下类固醇注射在改善外展范围方面优于安慰剂(均值加权差异为35度(95%置信区间14至55))。
几乎没有证据支持或反驳常见肩部疼痛干预措施的疗效。除了需要进一步设计良好的临床试验外,还需要更多研究来建立统一的肩部疾病定义方法,并开发在受影响人群中有效、可靠且灵敏的结局指标。